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Mechanism of insulin-stimulated electrogenic sodium transport
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Mechanisms of insulin-stimulated electrogenic sodium transport. Stud-
ies were performed to determine the signal transduction mechanism
involved in the onset of insulin stimulated electrogenic sodium transport
(Ieq) in cultured A6 cells. Insulin stimulated Ieq at a threshold concen-
tration of one nM and a half-maximum concentration of approximately 3
nM. The onset of action occurred within 10 seconds and the increase in Ieq
was augmented by pretreatment with aldosterone, similar to the action of
vasopressin. Insulin stimulated an increase in Ca in a dose-dependent
manner that involved release from intracellular stores. Hormone stimu-
lated Ieq was dependent on increases in Ca because pretreatment with
5, 5' dimethyl BAPTA/AM blocked the increase in sodium transport.
further studies with dihydroxyclorpromazine, trilluoperazine and genistein,
inhibitors of PKC, Ca dependent, calmodulin dependent kinases and
tyrosine kinase, respectively, suggested that the action of insulin was
dependent on activation of these kinases. In contrast, insulin stimulated
Ieq was independent of changes in cAMP, because insulin did not increase
the accumulation of cAMP, and inhibition of adenylate cyclase with 2', 5'
dideoxyadenosine did not affect transport. These results suggest that
insulin, as previously shown for aldosterone, activates apical membrane
amiloride sensitive sodium channels by a calcium-dependent second
messenger system.
Patients with essential hypertension, obesity and NIDDM ex-
hibit an increase in plasma insulin levels to compensate for
resistance to insulin-mediated glucose uptake by skeletal muscle
and other tissues [1, 21. It has been proposed that elevation of
blood pressure in these clinical conditions may result from
insulin-stimulated sodium retention. In euglycemic insulin-clamp
studies, modest elevations of plasma insulin produced marked
reductions in sodium excretion in healthy young men [3, 4].
Similar experiments in the dog indicated that insulin stimulated
sodium absorption at a site in the distal nephron [5]. In a recent
report, Stenvenkel and associates examined the action of insulin
in normal individuals with the insulin clamp technique, using
fractional reabsorption of lithium as a means to distinguish
sodium reabsorption in proximal and distal nephron segments [6].
Compared to control values the infusion of insulin to levels of 41
and 90 U/ml reduced sodium excretion in a dose-dependent
manner, in association with an increase in sodium reabsorption in
distal nephron. Insulin receptors have been demonstrated in all
nephron segments in the mammalian kidney, including the corti-
cal collecting tubule [7] where microperfusion studies in the rat
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and rabbit have shown that vasopressin and aldosterone induced
changes in sodium absorption, characterized by an active electro-
genie transport mechanism [8—10]. It seems likely, therefore, that
insights into the cellular mechanism regulating insulin-stimulated
sodium transport will be important in the development of clinical
treatment strategies, if the proposed correlation between hyper-
insulinemia and hypertension is confirmed.
Insulin, in nanomolar concentrations, is reported to stimulate
electrogenic sodium transport in toad bladder epithelium and
cultured A6 cells, used as experimental models of the cortical
collecting tubule, by activating apical cell membrane sodium
channels in a manner similar to the actions of aldosterone and
vasopressin [11, 12]. Although important insights have been
obtained in the cellular action of insulin in regulating carbohy-
drate, lipid and protein metabolism [13], there is little information
on the signal transduction mechanism involved in insulin-stimu-
lated electrogenic sodium transport. The present study was there-
fore performed to characterize insulin-stimulated sodium trans-
port in cultured renal epithelial cells, and, using this preparation
as an experimental model, to explore the signal transduction
mechanism involved in insulin regulation of apical membrane
sodium permeability.
Methods
Experiments were performed on A6D2 cells, a clone of the
established A6 cell line derived from the kidney of Xenopu.s laevis.
Cells were grown to confluency, during passages 80-87, on milli-
cell-HA cups (Millipore Corp., Bedford, Massachusetts, USA)
and were maintained in media that contained DMEM (Gibco,
Grand Island, New York, USA), glutamine (2 mM), penicillin (100
U -m1'), streptomycin (100 jrg ml1), 10% fetal bovine serum
(FBS), and NaHCO3 (8 mM). The final composition of culture
media contained (mM):Na, 94; Cl, 94; K, 4; HCO3, 8; Ca, 1.7 and
pH of 7.6. Since studies in this laboratory confirmed the findings
of a recent report [14] that demonstrated that FBS can be
removed from media about four days after subculture without
alteration in basal function or hormone responsiveness, FBS was
employed in culture media for only four to six days after subcul-
ture. Experiments were performed 10 to 14 days after subculture
when transmembrane resistance was maximal. Cells were main-
tained at 27°C in a humidified incubator gassed with 1% C02, and
were passaged at intervals of —7 to 10 days. Experiments were
performed under sterile conditions in a hood.
The active surface area of cups used in transport studies was 0.6
cm2, and the potential differences across confluent monolayers
was measured with Ag/AgC12 electrodes (Brede Scientific, East
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Haven, Connecticut, USA). Current was passed with a model
DVC-1000 voltage/current clamp apparatus (WPI Industries,
Sarasota, Florida, USA) to estimate transepithelial resistance
(RT), which ranged from 2,000 to 6,000 ITt cm2. The short circuit
current, Isc, has been reported to equal net sodium transport in
differentiated monolayers of A6 cells [15] and during insulin
stimulation in this cell line [16]. In the present study the equiva-
lent short circuit current (Ieq) was calculated from the open
circuit estimates of VT and RT, using Ohm's law, and represents
the net current associated with active ion flow when VT =0 mV.
This method has theoretical advantages over the estimate of Isc in
which a current is continuously applied to reduce V to zero,
because ion flow across the apical membrane is not altered due to
hyperpolarization. Data are shown as the change in Isc observed
in control and experimental monolayers over time compared to
the value at time zero. Although basal Ieq varied between
approximately 1 and 5 tA cm2 between different passages,
changes induced by agonists were proportional to basal values.
When chemical probes were dissolved in ETOH or DMSO the
solvents were diluted 1:100 or more since previous studies showed
an absence of cell toxicity under these conditions [17]. A similar
concentration of solvents was used in control groups. In studies
designed to examine the effect of inhibitors of adenylate cyclase
and kinases, inhibitors were added to bathing media 15 to 30
minutes before the addition of insulin to the basal surface of
monolayers, except for dimethyl-BAPTA/AM which was added
three hours before the test agent.
The estimate of levels of cAMP was performed with the RIA kit
supplied by Biomedical Technology, Inc., on cells grown on
permeable, transparent Falcon 3090 cell culture inserts with an
active surface area of 4.5 cm2. These membranes were used to
obtain a larger volume of cells and to facilitate complete removal
of cells from the membrane for the assay. Comparison of insulin
responsiveness of cells grown concurrently on millipore-HA and
Falcon membranes, of comparable size (0.6 cm2), demonstrated
similar transport characteristics. On millipore-HA membranes the
basal and stimulated values for Ieq were 1.7 0.1 and 6.2 0.4
A cm2, respectively, while on Falcon membranes they were
1.8 0.1 and 7.1 0.4 tA cm2, respectively. The phosphodi-
esterase inhibitor RO-201724, that does not bind to adenosine
receptors [18], was added to the bathing solution in a concentra-
tion of 100 jtM 15 minutes before addition of insulin or vasopres-
sin and the experiment was terminated 10 minutes after addition
of agonists. After addition of 1 ml cold 6% TCA and disruption of
cells with mechanical scraping, the specimen was centrifuged at
2500 rpm to remove particulate material. Cyclic nucleotides were
extracted from the supernatant, maintained on ice, by the addition
of 1 ml of Freon and tri-N-octylamine (1:1, vol/vol) [19]. Samples
were vortexed for one minute to ensure adequate mixing, and the
mixture separated into a lower phase of Freon that contained
unreacted octylamine and octylamine perchlorate, and an upper
neutral aqueous phase that contained the cyclic nucleotides. This
method of separation was associated with 100% recovery of
3H-cAMP. The activity of 1125 cAMP was estimated on a Searle
gamma counter. Protein concentration was determined by the
Lowry method.
Intracellular calcium, Car, was estimated in suspended cells,
rather than in cells adherent to porous transparent membrnes,
because the autofluorescence of commercially available mem-
branes reduced an adequate signal to noise ratio. We avoided
growing cells on non-porous surfaces because studies with vaso-
pressin indicated a lack of response, reflected by no increase in
cAMP accumulation, suggesting that receptors either did not
develop or were inaccessible to the hormone. We assumed that
this restriction also applied to insulin. In these experiments,
however, suspended cells were derived from permeable Falcon
membranes to permit development of cellular polarity. Cells were
obtained from the membranes by gentle mechanical scraping after
exposure to 5 mM EGTA for approximately three minutes, to
avoid exposure to trypsin.
The method used for loading cells with aequorin and measuring
Ca has been reported previously by this laboratory [20]. Ae-
quorin is a photoprotein that generates a blue-green light of 470
n upon binding Ca ions. Photons emitted are recorded with a
photomultiplier, and light intensity is expressed in luminescence
units expressed in nAmps. Aequorin has several advantages over
fluorescent indicators, including absence of autoflourescence,
intracompartmentalization and rapid leakage from the cell.
Insulin, arginine vasopressin, trifluoperazine, Freon, tri-N-oc-
tylamine and genistein, were obtained from Sigma (St. Louis,
Missouri, USA). Aequorin was purchased from Friday Harbor
Photo Protein (Friday Harbor, Washington, USA). Additional
chemicals were obtained from the following vendors: RIA kit for
estimates of cAMP, Biomedical Technology, Inc. (Stoughton,
Massachusetts, USA); 2', 5', dideoxyadenosine (DDA), Pharma-
cia (Milwaukee, Wisconsin, USA); Ro-201724, Biomol Research
Lab, Inc. (Plymouth Meeting, Pennsylvania, USA); 5, 5' dimethyl-
BAPTA/AM, Molecular Probes (Eugene, Oregon, USA); amilo-
ride, a gift from Merck Sharp & Dohme Research Labs (Rahway,
New Jersey, USA); and 7,8-dihydroxyclorpromazine was provided
by Research Biochemical, Inc., as part of the Chemical Synthesis
Program of the National Institute of Mental Health, Contract
278-90-007(BS).
The unpaired Student's t-test was used to make statistical
comparisons, and a P < 0.05 was regarded as denoting a statistical
difference.
Results
The addition of insulin to the basal solution of monolayers of
A6 cells caused an increase in equivalent short circuit current
(Ieq) at a threshold concentration of at least one n and a
half-maximum concentration of approximately 3 n. Compared to
the control change in Ieq over 30 minutes of 0.3 0.1 A cm2,
insulin resulted in the following increases above basal transport in
cm2: 1 nM, 0.8 0.1; 3 nM, 1.0 0.1; 5 nM, 1.2 0.1; 10 nM,
1.5 0.3; 50 nM, 2.0 0.03, as shown in Figure 1A. Figure lB
shows that addition of amiloride (100 .LM) to apical solution
inhibited both basal and insulin-stimulated Ieq, consistent with
the notion that Ieq reflected ion flow through amiloride-sensitive
sodium channels. To determine the time of onset of the action of
insulin, VT was measured continuously across the active mem-
brane of culture cups, maintained at 27°C in the incubator, and
values were displayed on a strip recorder. This approach permit-
ted estimates of rapid changes in VT and avoided minor changes
in experimental conditions. As shown in Figure 2, an increase in
VT was observed within 10 seconds after addition of insulin to the
basal solution. Studies performed under the same conditions
demonstrated that the time of onset and initial rate of increase in
VT after addition of vasopressin to the basal solution was similar
to insulin induced effects (data not shown). Measurements during
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the subsequent time course of the action of insulin showed that
VT achieved about 80 percent of the maximal increment of VT in
30 minutes. In experiments designed to examine the effect of
various agonists and inhibitors on the action of insulin in large
populations of monolayers measurements were performed at 30
minutes.
The effect of insulin on Ieq appeared to involve the insulin
receptor rather than the receptor of insulin-like growth factor
because the actions of IGF1 and IGF2 required a minimal
concentration of 100 nrt to stimulate Isc (data not shown). Since
previous studies [21] demonstrated that the affinity of the insulin
receptor for IOF1 and IGF2 is 10 to 100 times lower than the
affinity for insulin, it seems likely that the action of IGF isoforms
on the A cell was due to binding to the insulin receptor.
Previous studies in the toad urinary bladder and cultured A6
cells showed that pretreatment with aldosterone markedly aug-
mented the action of vasopressin to stimulate electrogenic sodium
transport [22, 23], suggesting that the signal transduction mecha-
nism of aldosterone was interactive with that of vasopressin.
Experiments were therefore performed to determine whether
aldosterone pretreatment affected the mechanism by which insu-
Fig. 1. Dose response of insulin stimulated-Ieq
and effect of amiloride. (A) Demonstrates
change in Ieq compared to baseline value by
untreated monolayers and after addition of
insulin to basal solution over 30 mm. (B)
Change in Ieq 30 mm after addition of insulin
to basal solution and 5 mm after addition of
amiloride to apical solution of insulin
stimulated monolayers. There were 6 culture
cups in each group. Values indicate mean
SEM.
Fig. 2. The time course of insulin stimulated
sodium transport, reflected by changes in Vi, in a
representative tracing. (A) Demonstrates the
initial time course in sec after addition of 10
n insulin to basal solution at 0 sec. (B) Shows
the subsequent time course in mm in the same
experiment. Similar results were observed in 5
other experiments.
lin, in nanomolar concentrations, stimulated sodium transport.
Figure 3A shows that incubation of monolayers of A6 cells with
aldosterone for 16 hours, markedly augmented the insulin-in-
duced increase in Ieq. Compared to the increase in Ieq above
control (0,03 0.06 A cm2) of 1.4 0.3 j.A cm2 when 10
n insulin alone was added to monolayers, the insulin stimulated
increase in Isc in aldosterone-pretreated cells was 7.7 2
cm2 (P < 0.001). The effect of pretreatment with aldoste-
rone on the action of vasopressin is shown for comparison in
Figure 3B. These results suggest that the signal transduction
mechanism of aldosterone is interactive with the mechanisms
involved in the cellular action of both insulin and vasopressin.
Additional experiments were conducted to obtain insights into
the signal transduction pathway utilized by insulin to stimulate
sodium transport. The current theory of insulin action proposes
that interaction of insulin with its receptor causes autophosphor-
ylation of tyrosine residues on the /3-subunit of the receptor by
tyrosine kinase. Activation of tyrosine kinase also initiates subse-
quent activation and inactivation of intermediary kinases and
phosphatases that modulate changes in cell expression [241.
Recent studies, however, suggest that some actions of insulin do
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Fig. 3. Affect of pre-treatment with aldosterone
on insulin and vasopressin stimulated Ieq. (A)
Demonstrates change in Ieq compared to
baseline value in untreated monolayers, 30 mm
after addition of insulin alone, and 30 mm after
addition of insulin to monolayers pre-treated
with aldosterone for 16 hr. (B) Shows the effect
of pretreatment with aldosterone on the action
of vasopressin under the same conditions.
Similar results were observed with 3 other
experiments with each hormone. The symbol *
indicates P < 0.05 compared to insulin and
vasopressin alone. There were 6 culture cups in
each group. Values indicate mean SEM.
Fig. 4. The effect of pretreatment with genistein
for 30 mm on the action of insulin and
vasopressin stimulated Ieq. (A) The effect of
pretreatment on the action of insulin. (B) The
effect of pretreatment on the effect of
vasopressin. The symbol * indicates P < 0.05
compared to addition of hormone in the
absence of genistein. There were 6 cups in each
group. Values are mean SEM. Similar results
were observed in 5 additional experiments.
not involve activation of tyrosine kinase [25]. To determine
whether the action of insulin on sodium transport was tyrosine
kinase dependent, the effect of genistein, a specific tyrosine kinase
inhibitor, on Ieq was examined [26]. Genistein inhibited the
insulin-stimulated Ieq by approximately 50% in a concentration of
10 fLM. The Ki for the EGF receptor was reported to be 22 iM in
in vitro experiments [27]. Higher concentrations of genistein,
however, did not reduce insulin-induced Isc by more than 50%, as
shown in Figure 4A. Genistein did not inhibit basal transport.
Basal Ieq levels were 2.3 0.4 and 2.9 0.6 .tA cm2 at 0 and
30 minutes in controls and were 3.4 X 0.6 and 3.6 0.5 tA• cm2
at the same time intervals in genestein treated monlayers. Figure
4B indicates that genistein had no inhibitory effect on the action
of vasopressin. These results suggest that the action of insulin on
sodium transport is dependent on activation of tyrosine kinase,
but contrast with reports in which genistein inhibited the action of
insulin and EGF > 50 % in other cell types [26].
Because the cellular action of vasopressin, which also binds to
cell surface receptors, on electrogenic sodium transport has been
proposed to involve the second messenger 3,5-cyclic adenosine
(cAMP) [28], the cellular accumulation of cAMP were measured
in insulin treated A6 cells. Compared to the control value, of 48
6 pmol/mg protein, the level of cAMP in cells treated with insulin
in concentrations of 10 nM (47 1 pmol!mg protein) and 100 nM
(39 1 pmol/mg protein), were not increased (P> 0.05 compared
to control). The lack of an effect of insulin on cAMP accumulation
corresponds to prior experiments on toad bladder epithelium in
which micromolar concentrations of insulin were used [29]. Fur-
ther studies were performed to evaluate the possible role of
cAMP as a second messenger in the cellular action of insulin in
the absence and in the presence of 2', 5' dideoxyadenosine
(DDA). DDA binds to the P site in adenylate cyclase and
completely inhibits the action of vasopressin to increase cAMP
and hydraulic water transport in toad urinary bladder [29, 30].
Other studies have shown that DDA (100 tM) inhibits basal and
dopamine stimulated cAMP in membrane vesicles from renal
cortex [31, 32] and completely blocked the action of dopamine to
increase cAMP and inhibit Na-K-ATPase in rabbit CCI' [33].
Figure 5A shows that while insulin did not increase cellular levels
of cAMP above control, DDA resulted in a modest, but statisti-
cally significant, decrease in cAMP below control, suggesting
inhibition of basal adenylate cyclase activity. DDA did not affect
basal transport. Basal Ieq levels were 1.7 0.3 and 1.4 0.2
JLA cm2 at 0 and 30 minutes in controls and were 1.7 0.3 and
1.7 0.2 j.tA cm2 in DDA treated monolayers. As shown in
Figure SB, DDA completely blocked the vasopressin stimulated
increase in cAMP, demonstrating the action of DDA to down-
regulate the enzyme under the conditions of this experiment. In
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Fig. 5. Evidence that insulin-induced cAMP is
independent of increase in cAMP. (A) Shows that
insulin does not increase the cellular
accumulation of cAMP, while 2' 5'
dideoxyadenosine (DDA) causes a modest
decrease in basal levels. (B) Demonstrates that
DDA is an active inhibitor of adenylate cyclase
and blocks vasopressin-stimulated increase in
cAMP. (C) Shows that DDA did not inhibit
insulin-stimulated Ieq. The symbol * indicates
P < 0.05 compared to insulin or vasopressin
alone. There were 6 cups in each group. Values
indicate mean SEM. The difference between
control levels of cAMP in A and B reflects
differences in observed levels between different
cell passages.
further experiments, DDA did not inhibit the insulin stimulated
increase in Ieq, as shown in Figure 5C. These data therefore,
provide strong evidence for the absence of a role in cAMP in the
mediation of the action of insulin-induced increase in Ieq.
To determine whether changes in Ca were involved in the
transduction system mediated by insulin to increase electrogenic
sodium transport, estimates of Ca were made with the photo-
protein aequorin. As shown in Figure 6 A to C insulin stimulated
an increase in Ca in a dose-dependent manner over a range of
concentrations from 10 flM to 1 /.tM. Because the increase in Ca
in a calcium-free bathing solution (Fig. 6D) was similar to the rise
in Ca when cells were bathed in Ringer's solution containing 1.7
mM calcium, it seemed likely that calcium was released from
intracellular stores of calcium.
Further studies were performed to determine whether insulin
stimulated sodium transport was dependent on an increase in
Can. Monolayers were incubated in medium containing 50 jM of
5, 5' dimethyl BAPTAIAM. This concentration was shown in
previous studies from this laboratory to inhibit the aldosterone-
induced transient increase in Ca by approximately 80% [17].
Figure 7 shows that 100 n of insulin stimulated Ieq by 1.6 0.1
AJcm2 after 30 minutes. In contrast, there was no increase in Ieq
secondary to the action of insulin when cells were loaded with the
calcium chelator BAPTA, compared to untreated control cells.
Earlier studies from this laboratory demonstrated that intracellu-
lar BAPTA'AM was nontoxic for periods of 24 hours, and did not
affect basal levels of Ca or basal levels of Ieq or transepithelial
resistance, R, of monolayers [171. In the present series, R of
approximately 3000 ci cm2 was similar in control and BAPTA
treated cells. These results therefore provide evidence that insu-
lin-stimulated increases in sodium transport are dependent on
hormone-induced changes in Because second messenger
systems that involve calcium usually activate calcium-dependent
kinases, further experiments were conducted to evaluate the roles
of protein kinase C and calmodulin dependent kinases.
To determine whether the action of insulin on sodium transport
involved protein kinase C as a second messenger, monolayers of
A6 cells were exposed to dihydroxychiorpromazine (DHCP), a
specific inhibitor of protein kinase C with a K of 8 sM, compared
to protein kinase A (I( 200 SM), calmodulin kinase (K1 65 j.M)
and casein dependent kinase (K1 218 M) [34]. Figure 8A shows
the inhibitory effect of DHCP on insulin-induced Isc. Compared
to the control value of 1.4 0.5 j.A cm2, Ieq was reduced to
0.6 0.2 rA cm2 and 0.7 0.3 jtA cm2 with 5 and 10 rM
of DHCP respectively, and to zero at concentrations of 30 p.M or
higher concentrations. In contrast to the inhibitory affect on
insulin-stimulated transport, DHCP did not reduce basal trans-
port. Basal levels of Ieq were 2.3 0.4 and 2.9 0.6 p.A cm2
in controls at 0 and 30 minutes, respectively, and 3.3 0.5 and
3.9 0.5 p.A cm2 at the same intervals, respectively, in the
experimental group.
In further studies, we examined the action of trifluoperazine, an
inhibitor of calmodulin dependent kinases, on the action of
insulin. Figure 8B shows that trifluoperazine inhibited insulin-
stimulated sodium transport more than 80% at 5 p.M and com-
pletely inhibited transport at 20 p.M. Basal transport, in contrast,
was not inhibited by trifluoperazine. The basal levels were 2.9
0.6 and 2.6 0.8 pA cm2 in controls at 0 and 2 hours, and were
1,9 0.5 and 2.3 0.3 p.A cm2 in the experimental group at the
same time intervals. This inhibitory concentration of trifluopera-
zine corresponds to the K1 reported to block the action of calcium
dependent, calmodulin dependent kinases in other types of cells
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[351. Taken together, these results suggest insulin-induced sodium
transport is dependent on activation of protein kinase C and
calcium dependent/calmodulin dependent kinase.
Discussion
Insulin-stimulated electrogenic sodium transport was initially
demonstrated in amphibian epithelium in 1963 [36]. Subsequent
studies showed that insulin activated receptors on the basal side of
the membranes [11, 16], and increased sodium transport within 30
minutes, by a mechanism that was not dependent on transcription
or new protein synthesis in contrast to aldosterone [11, 291.
Furthermore, because pretreatment with aldosterone resulted in a
larger increase in insulin-stimulated transport than the sum of the
individual effects of aldosterone and insulin alone, it seemed likely
the synergism reflected interaction between the mechanisms of
action of each hormone [37].
Although early studies used micromolar or higher concentra-
tions of insulin, Cox and Singer [11] and Blazer-Yost, Cox and
Furlanetto [38] reported that the threshold, half-maximal and
maximal natriferic concentrations of insulin in urinary toad blad-
der were —0.1, 1 and 10 n, respectively, which corresponded to
the half-maximal binding of the insulin receptor of 3 to 10 n. The
onset of insulin-stimulated sodium transport was demonstrated
within five minutes. This range of concentrations is similar to the
findings in the present study with A6 cells.
Initial reports suggested that insulin-stimulated electrogenic
sodium transport was due to activation of the sodium pump [36,
39], and subsequent experiments in toad bladder [40] and skeletal
muscle [41] have supported the view that insulin activates the
sodium pump. Recent experiments, however, have demonstrated
that insulin-stimulated sodium transport is primarily induced by
an increase in sodium permeability in the apical cell membrane,
reflected by a reduction in apical membrane resistance and
depolarization [42, 43]. Moreover, Marunaka and associates dem-
onstrated, in patch clamp studies, that insulin increased specific
membrane permeability for sodium in A6 cells by increasing the
number of activated sodium channels in apical membrane and
increasing the length of time that channels remained open [12].
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Fig. 6. Effect of insulin on intracellular calcium,
Car, as measured with aequorin. A-C. The
effect of insulin on changes in Ca over a
concentration range from 10 flM to 1 !LM. Cells
were bathed in mammalian Ringer's solution
containing 1.7 mrvi Ca2t D. The effect of
insulin 100 flM on Ca when cells were bathed
in a calcium-free solution. These traces are
representative of 6 separate experiments.
672 Rodriguez-Commes et a!: insulin-induced Na transport
0
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+
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Fig. 7. Effects of 5, 5' dimethyl BAPTA on insulin stimulated Ieq. Results
indicate changes in Ieq compared to baseline over 30 mm after addition of
insulin to basal solution. BAPTA was added to solutions bathing both cell
surfaces 3 hr prior to insulin treatment. Similar results were observed in an
additional experiment. The symbol * indicates P < 0.05 compared to
group treated with insulin alone. There were 6 cups in each group. Values
are means SEM.
The present study extends the characterization of the cellular
action of insulin in epithelial cells by demonstratting that the
onset of increased sodium transport occurs within 10 seconds,
similar to the action of vasopressin, and supports the notion that
the action of insulin is dependent on binding to insulin receptors,
rather than IGF receptors. In addition, this study shows that
synergism with aldosterone occurs with nanomolar concentrations
of insulin.
A primaty aim of the present study was to investigate the signal
transduction mechanism involved in insulin-stimulated electro-
genie sodium transport. Insulin is known to induce multiple types
of effects in most cells, although some effects are tissue or cell
specific [13]. Since purification of the insulin receptor, a consensus
has emerged that autophosphorylation of one or more tyrosyl
residues on the receptor activates tyrosine kinase activity towards
other proximal intermediate proteins, and is essential for biolog-
ical activity. In this schema the final steps in the action of insulin
to affect different types of cellular effects depends on activation of
specific signal transduction pathways [13, 24], In the present study
we found that the specific tyrosine kinase inhibitor genistein, not
unexpectedly, inhibited insulin-stimulated electrogenic sodium
transport, suggesting that receptor tyrosine autophosphorylation
or receptor kinase substrate tyrosine phosphorylation plays a role
in the transduction process. The absence of complete inhibition
suggests, however, that a parallel non-tyrosine kinase dependent
pathway is also involved. Recent studies have suggested that some
effects of insulin action, such as insulin-induced pyruvate dehy-
drogenase and glycogen synthase activity in rat adipocytes, are not
dependent on tyrosine kinase activation [251.
Experiments were performed to determine whether insulin-
induced electrogenic sodium transport involved one of the two
major pathways shown to transduce ligand stimulated ion trans-
port in epithelial and nonpolarized cells. These pathways include:
(1) the cyclic nucleotide 3, 5-cyclic adenosine (cAMP) produced
by activation of adenylate cyclase; and (2) increased intracellular
calcium, Car, either due to release from non-mitochondrial
cellular stores of calcium or stimulation of calcium influx. These
studies showed that insulin increased Ca over a range of
concentrations from 10 nM to 1 jLM, in a dose-dependent manner.
Because insulin induced an increase in Ca when cells were
bathed in a calcium free-bath, it seems likely that calcium was
released from intracellular stores, although a concurrent rise in
calcium influx into the cell cannot be excluded by the present
study. Further studies were performed to determine whether
insulin-stimulated sodium transport was dependent on increases
in Car. The marked inhibition of insulin-stimulated Ieq when
cells were exposed to 5, 5' dimethyl BAPTA provides strong
evidence that insulin action is a calcium dependent process.
Previous reports have demonstrated that growth hormones,
including insulin, employ a calcium-dependent transduction sys-
tem for some effects. For example, the action of PDGF, EGF and
FGA in fibroblasts require an increase in Car, derived from
intracellular stores, to stimulate mitogenesis and DNA synthesis
[44, 45]. Insulin was also shown to stimulate calcium influx in
order to increase glucose uptake in adipocytes [46—481 and inhibit
vasopressin induced contractable responses in cardiac and smooth
muscle cells [491.
Further experiments were performed to determine whether
insulin-stimulated sodium transport was dependent on an increase
in cAMP, because the action of vasopressin to increase electro-
genie sodium transport has been linked to activation of adenylate
cyclase and increased levels of cAMP [28]. Previous reports
suggest that insulin decreases cAMP levels in most tissues [50] and
no change in cAMP levels were found when toad bladder cells
were exposed to micromolar concentrations of insulin [29]. In the
present study, nanomolar concentrations of insulin, in concentra-
tions shown to stimulate sodium transport, were not associated
with increased accumulation of cAMP. Moreover, insulin-stimu-
lated sodium transport was not inhibited under conditions where
adenylate cyclase was blocked with 2', 5' dideoxyadenosine.
Taken together, these studies and previous reports provide strong
evidence that the action of insulin to stimulate electrogenic
sodium transport is not cAMP dependent.
We also evaluated the possible roles of two classes of calcium
dependent kinases, capable of phosphorylation of seryl and
threonyl residues, in the cellular action of insulin. DHCP, a
specific inhibitor of protein kinase C in concentrations < 10 ILM,
and trifluoperazine, an inhibitor of calmodulin dependent kinases,
reduced insulin stimulated Ieq with apparent K values near
inhibitoty concentrations in in vitro systems [34, 35]. Although
these results suggest that both classes of kinases are involved in
the action of insulin, further experiments are required to confirm
their participation by direct estimates of enzyme activities. It
should be noted that insulin has been reported not to hydrolyze
phosphatidylinositol, phosphatidyl-inositol 4,5-bisphosphate or
phosphatidylcholine in some mammalian cells [51]. However,
Civan and associates provided evidence suggesting that insulin-
stimulated sodium transport in frog skin was mediated by activa-
tion of protein kinase C [52]. In addition, insulin-induced in-
creases in diacyiglycerol, the natural activator of protein kinase C,
has been reported in myocytes due to de novo synthesis of
phosphatidic acid [53] and hydrolysis of phosphatidylinositol-
glycan [54]. In these cells insulin increased protein kinase C
activity in cell membrane and cytosal within 60 seconds [551.
1—
j *
Control Insulin
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These results suggest that protein kinase C is involved in some
actions of insulin.
In summary, these studies and reports of previous studies
indicate that insulin stimulates electrogenic sodium transport by
rapidly activating amiloride-sensitive sodium channels in apical
cell membrane, in a manner similar to the action of vasopressin.
The cellular action of insulin is dependent, at least in part, on
tyrosine kinase activation, probably in the proximal portion of the
transduction pathway and requires an increase in intracellular
calcium to induce apical membrane conductance for sodium.
There is no evidence that cAMP is involved in the mechanism of
insulin action. Since the cellular action of aldosterone is also
cAMP independent, but dependent on an increase in Car, at
least during the onset of action, it seems possible that both
aldosterone, which binds to an intracellular receptor, and insulin,
which binds to a surface receptor, may employ a common
mechanism to stimulate apical sodium permeability in the final
portion of their transduction mechanisms.
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